Navigation Links
IGERT fellows to design biodevices using flexible electronics
Date:9/17/2007

ipate in the Cornell-based team research efforts, called Team Focus Projects.

These student project teams will design sensors and other biodevices that incorporate the most recent advances in biocompatible materials and flexible electronics, explained Graham Kerslick, associate director of the NBTC. Some of the students also will work in labs overseas at such partner institutions as Seoul National University in Korea and Cambridge University in the United Kingdom.

IGERT fellows will take courses in areas where materials science, biology and other applications converge, and students from other institutions will participate in the courses through such distance-learning technologies as videoconferencing.


'/>"/>
Contact: Press Relations Office
pressoffice@cornell.edu
607-255-6074
Cornell University News Service
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Newly discovered pathway might help in design of cancer drugs
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
4. Designing vaccines by computer
5. New design : complete
6. Mouse with designer liver has enhanced glucose tolerance, insulin response
7. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
8. Redesigned protein accelerates blood clotting
9. Two designer drugs hit same lung cancer target, but only one is effective
10. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
11. Scientists and engineers apply natures design to human problems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Study confirms association between tobacco smoke and behavioral problems in children 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Supportive materials will help regenerate heart tissue 2SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 1SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 2SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 3SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 4Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 1Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 2Is RTA a new potential option for the treatment of hydatid cysts 3F 52656 1Is RTA a new potential option for the treatment of hydatid cysts 3F 52656 2Is RTA a new potential option for the treatment of hydatid cysts 3F 52656 3